Renewal of Provisional Consent to the Distribution of a New Medicine Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Docetaxel trihydrate equivalent to 40 mg/mL docetaxel in 0.5 mL and 2 mL; 13% w/w ethanol 95% in water for injection 1.5 mL and 6 mL (diluent) Infusion, concentrate with diluent Rhone-Poulenc Rorer SA., Usine de Vitry, Vitry sur Seine, France and Rhone-Poulenc Rorer Limited, Dagenham, Essex, United Kingdom Taxotere Note: This consent is valid for 2 years from the 23rd day of May 1998. Dated this 16th day of June 1998. G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.